Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA ZYDUS LIFESCIENCES DISHMAN PHARMA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 30.0 20.1 149.0% View Chart
P/BV x 3.3 2.4 139.9% View Chart
Dividend Yield % 0.7 0.6 106.8%  

Financials

 DISHMAN PHARMA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
ZYDUS LIFESCIENCES
Mar-22
DISHMAN PHARMA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs374674 55.6%   
Low Rs129331 38.9%   
Sales per share (Unadj.) Rs197.0149.1 132.1%  
Earnings per share (Unadj.) Rs21.222.7 93.2%  
Cash flow per share (Unadj.) Rs34.729.7 116.9%  
Dividends per share (Unadj.) Rs2.002.50 80.0%  
Avg Dividend yield %0.80.5 159.7%  
Book value per share (Unadj.) Rs179.9166.1 108.3%  
Shares outstanding (eoy) m80.701,023.74 7.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.33.4 37.9%   
Avg P/E ratio x11.922.1 53.7%  
P/CF ratio (eoy) x7.316.9 42.9%  
Price / Book Value ratio x1.43.0 46.2%  
Dividend payout %9.411.0 85.8%   
Avg Mkt Cap Rs m20,307514,277 3.9%   
No. of employees `000NANA-   
Total wages/salary Rs m5,35521,777 24.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,898152,652 10.4%  
Other income Rs m2652,354 11.3%   
Total revenues Rs m16,163155,006 10.4%   
Gross profit Rs m4,10334,427 11.9%  
Depreciation Rs m1,0917,130 15.3%   
Interest Rs m9441,270 74.4%   
Profit before tax Rs m2,33428,381 8.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6245,117 12.2%   
Profit after tax Rs m1,71023,264 7.4%  
Gross profit margin %25.822.6 114.4%  
Effective tax rate %26.718.0 148.2%   
Net profit margin %10.815.2 70.6%  
BALANCE SHEET DATA
Current assets Rs m11,018122,614 9.0%   
Current liabilities Rs m9,51778,394 12.1%   
Net working cap to sales %9.429.0 32.6%  
Current ratio x1.21.6 74.0%  
Inventory Days Days5793 61.5%  
Debtors Days Days380 4.4%  
Net fixed assets Rs m18,787144,382 13.0%   
Share capital Rs m1611,024 15.8%   
"Free" reserves Rs m14,354168,972 8.5%   
Net worth Rs m14,516169,996 8.5%   
Long term debt Rs m4,1893,621 115.7%   
Total assets Rs m29,805266,996 11.2%  
Interest coverage x3.523.3 14.9%   
Debt to equity ratio x0.30 1,355.0%  
Sales to assets ratio x0.50.6 93.3%   
Return on assets %8.99.2 96.9%  
Return on equity %11.813.7 86.1%  
Return on capital %17.517.1 102.6%  
Exports to sales %24.90-   
Imports to sales %3.714.3 26.1%   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m59421,869 2.7%   
Fx inflow Rs m4,95263,065 7.9%   
Fx outflow Rs m69721,869 3.2%   
Net fx Rs m4,25541,196 10.3%   
CASH FLOW
From Operations Rs m2,78621,041 13.2%  
From Investments Rs m-1,52911,544 -13.2%  
From Financial Activity Rs m-941-8,683 10.8%  
Net Cashflow Rs m31723,729 1.3%  

Share Holding

Indian Promoters % 61.4 75.0 81.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 15.5 147.8%  
FIIs % 12.0 2.6 460.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 25.0 154.3%  
Shareholders   52,291 408,231 12.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on Dishman Pharma vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Cadila Healthcare Share Price Performance

Period Dishman Pharma Cadila Healthcare S&P BSE HEALTHCARE
1-Day 2.87% 2.28% 0.33%
1-Month -2.45% -3.70% 0.28%
1-Year 96.38% -13.04% -6.55%
3-Year CAGR 50.28% 16.15% 20.31%
5-Year CAGR 41.17% -1.98% 10.96%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 21 Points Higher | BHEL, RVNL Surge 10% to Hit 52-Week High | Why PNB Share Price is Rising(Closing)

Indian share markets traded in a rangebound manner throughout today's session to end flat.